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ardiovascular Magnetic Resonance Imaging:
urrent and Emerging Applications
oão A. C. Lima, MD, MBA, Milind Y. Desai, MD
altimore, Maryland
Magnetic resonance (MR) imaging is gaining importance in cardiology as the newest, most
complex, and rapidly emerging noninvasive test of choice for patients with a multitude of
cardiovascular problems. It has long been recognized to provide an accurate and reliable
means of assessing the function and anatomy of the heart and great vessels, but its emerging
role as one of the dominant imaging modalities in other aspects of cardiology such as
perfusion imaging, atherosclerosis imaging, and coronary artery imaging cannot be under-
stated. As MR technology evolves, newer therapeutic applications are also being developed,
including specific MR-compatible catheters for electrophysiology studies/ablation as well as
interventional cardiology related procedures, which may alter the way we practice cardiology
in the future. Also, MR is entering an important phase in its evolution, with an anticipated
exponential growth in its current applications and through the development of newer
molecular imaging applications. It is anticipated that such developments will be coupled to
the utilization of molecular markers to index biologic processes to allow for their in vivo
visualization. This combination of biochemical markers and imaging methodology will also
usher in an era of molecular imaging during which much progress in the diagnosis and
treatment of cardiovascular disease is anticipated. (J Am Coll Cardiol 2004;44:1164–71)
© 2004 by the American College of Cardiology Foundationm
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eagnetic resonance imaging (MRI) is of increasing impor-
ance in cardiovascular medicine. It is widely recognized to
rovide an accurate and reliable means of assessing function
nd anatomy of the heart and great vessels. Previously,
owever, the means to obtain magnetic resonance (MR)
mages of the cardiovascular system had been compromised
y extremely long examination times and specialized equip-
ent that was available only at specialized centers. With the
ecent development of cardiovascular MR scanners, the
pplications of this technique have become more widely
sed on a routine basis. The advantages and disadvantages
f this technology are listed in Table 1. In this review, we
riefly discuss the different clinical and emerging applica-
ions of cardiovascular MRI (Table 2).
SSESSMENT OF VENTRICULAR FUNCTION
agnetic resonance imaging, a highly accurate and repro-
ucible non-invasive technique for measuring ejection frac-
ion and ventricular volumes, is now considered a “gold
tandard” (1). Usually bright blood gradient echo sequences,
btained during a 15- to 20-s breath-hold, are used to cover
he entire left ventricle (LV) with short-axis views from the
From the Division of Cardiology, Department of Medicine, Johns Hopkins
niversity, Baltimore, Maryland. Dr. Lima is supported by RO1-AG021570-01
National Institute of Aging), RO1 HL66075-01 (National Institute of Health,
. W. Reynolds Cardiovascular Clinical Research Center), and HC-98-08 (National
eart, Lung, and Blood Institute).
Manuscript received February 11, 2004; revised manuscript received May 6, 2004,bccepted June 7, 2004.itral plane and slice thickness not exceeding 10 mm.
agnetic resonance imaging is the method of choice for
ongitudinal follow-up of patients undergoing therapeutic
nterventions (2). Also, the sample size needed to detect LV
arameter changes in a clinical trial is far less than other
maging modalities, which markedly reduces the time and
ost of patient care and clinical trials (3).
Regional myocardial function is best assessed using a
nique MR technique called myocardial tagging (4), com-
only acquired by special modulation of magnetization (5).
pecial modulation of magnetization is obtained by apply-
ng a radiofrequency pre-pulse perpendicular to the imaging
lane. This pre-pulse induces local changes in saturation
ithin their planes that label the heart muscle with a dark
rid and enables three-dimensional analysis of cardiac rota-
ion, strain (in the subendocardial, midwall, and subepicar-
ial layers), displacement, and deformation of different
yocardial layers during the cardiac cycle (6). The tags can
e applied immediately after the R-wave on the electrocar-
iogram to image systolic function or in late systole to image
iastolic function. Use of MR tagging methods has enabled
s to demonstrate reduced intramural myocardial contrac-
ion in pressure-overload hypertrophy with preserved LV
jection fraction. In coronary artery disease, the application
f MR tagging has enabled us to discern regional hetero-
eneity of myocardial function in the setting of ischemia,
nfarction, stunning, hibernation, and post-infarct remod-
ling (6). The use of MR tagging in cardiomyopathies is
riefly discussed next.
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ontrast-enhanced MRI is rapidly evolving as a means of
ccurately predicting myocardial viability. On first-pass
erfusion images, an area of hypoenhancement within the
nfarcted region, correlating with microvascular obstruction,
elated to “no reflow” inside the infarct zone has been
escribed (7,8). The second enhancement pattern is noticed
t 10 to 30 min after contrast injection (delayed hyperen-
ancement [DHE]) (Fig. 1) and can be depicted with a
reath hold inversion-recovery gradient echo sequence. The
HE can be used to detect changes after acute and chronic
yocardial infarction. After an acute infarct, the presence of
HE reflects myocardial necrosis and abnormal contrast
olecule kinetics (9–11) within infarcts, whereas in chronic
nfarction, it reflects increased concentration of gadolinium
on-viable, infarcted scar tissue (12). In patients with a
hronic myocardial infarction, DHE can accurately locate
nd determine the extent and transmurality of the infarct
nd denote its non-viability (13,14). Further development
f necrosis-specific contrast agents and refinement of MR
pectroscopy to assess regional chemistry and metabolism
ill enhance the utility of MRI.
SSESSMENT OF DIFFERENT CARDIOMYOPATHIES
agnetic resonance imaging has a high degree of accuracy
nd reproducibility in the visualization of LV and right
entricular (RV) morphology and function (15) and is fast
ecoming the gold standard for in vivo identification of the
henotype of cardiomyopathies (1).
ilated cardiomyopathy. In dilated cardiomyopathy, us-
ng gradient echo sequence, we can analyze wall thickening
16), impaired fiber shortening (17), and end-systolic wall
tress (which is a very sensitive parameter of a change in LV
Abbreviations and Acronyms
DHE  delayed hyperenhancement
HCM  hypertrophic cardiomyopathy
LV  left ventricle/ventricular
LVOT  left ventricular outflow tract
MR  magnetic resonance
MRI  magnetic resonance imaging
RV  right ventricle/ventricular
able 1. Advantages and Disadvantages of Magnetic
esonance Imaging
dvantages
Unparalleled resolution
Three-dimensional imaging capacity
Non-invasive
Non-toxic contrast agents
Ability to depict soft tissues
isadvantages
Long scan times
Artifacts including motion, respiratory, cardiac motion
Incompatibility with pacemakers, defibrillators, and aneurysm clipsvystolic function) (18). Magnetic resonance spectroscopy
as also revealed a change in phosphate metabolism in
ilated cardiomyopathy (19). A ratio of phosphocreatine to
denosine triphosphate is shown to have prognostic value in
ilated cardiomyopathy as it correlated with the clinical
everity of heart failure and may improve during clinical
ecompensation (19). Contrast-enhanced T1-weighted im-
ges are also helpful in detecting changes of acute myocar-
igure 1. Short-axis image of the heart obtained 10 min after contrast
njection revealing a hyperenhanced area (arrow) in the inferolateral left
able 2. Applications of Magnetic Resonance Imaging in
ardiovascular Medicine
urrent clinical applications
Assessment of right and left ventricular function, volumes, and mass
Assessment of myocardial viability
Assessment of different cardiomyopathies
Dilated cardiomyopathy
Hypertrophic cardiomyopathy
Arrhythmogenic right ventricular dysplasia
Restrictive cardiomyopathy
Sarcoidosis
Amyloidosis
Hemochromatosis
Endomyocardial fibrosis
Evaluation of pericardial diseases
Evaluation of cardiac and paracardiac masses
Benign
Malignant
Evaluation of congenital heart disease including shunts
Evaluation of valvular heart diseases
Evaluation of aortic diseases
Aortic dissection
Aortic aneurysm
Congenital disorders (coarctation of aorta and
Marfan’s syndrome)
Evaluation of pulmonary veins
merging applications
Assessment of myocardial perfusion and ischemia
Atherosclerotic plaque imaging
Coronary artery angiography and vessel wall imaging
Therapeutic magnetic resonance imaging for electrophysiology and
interventional proceduresentricular wall consistent with non-viable infarcted myocardium.
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Cardiovascular Magnetic Resonance Imaging September 15, 2004:1164–71itis (20) (increased gadolinium accumulation thought to be
he result of slow wash-in wash-out kinetics and diffusion
nto necrotic cells [9]) as well as increasing the sensitivity of
ndomyocardial biopsy by visualization of inflamed areas
hat would aid in determining a biopsy site (21). Magnetic
esonance tagging reveals that depressed LV function is
aused by depressed fiber and cross-fiber strain, the severity
f which parallels depressed LV function, but the transmu-
al gradients in these strains are preserved (6).
ypertrophic cardiomyopathy. Magnetic resonance im-
ging can assess LV mass, regional hypertrophy patterns,
nd different phenotypes of the disease (e.g., apical hyper-
rophic cardiomyopathy [HCM] [22], degree of left ven-
ricular outflow tract [LVOT] obstruction, systolic anterior
otion of the mitral valve [23]) and can monitor post-
yomectomy changes in HCM (24) (Fig. 2). Magnetic
esonance spectroscopy reveals changes in the phosphate
etabolism (25), whereas analysis of coronary sinus blood
ow helps in determining the alterations in coronary flow
eserve (26). Magnetic resonance planimetry can measure
he effective LVOT area during systole and can overcome
he problem of interstudy variability of the LVOT gradient,
ecause of its independence from the hemodynamic status
27). Myocardial tagging can accurately detect a reduction
n posterior rotation, reduced radial displacement of the
nferoseptal myocardium, and reduced three-dimensional
yocardial shortening. It can also detect the heterogeneity
f regional diastolic function in the septum (related to
yocardial fiber disarray) in different types of HCM,
ncluding asymmetric septal, symmetrical, and apical HCM
20). Magnetic resonance can be used to monitor patients
fter surgical and pharmacologic interventions (23) or alco-
olic septal artery ablation (28).
rrhythmogenic RV dysplasia. Magnetic resonance im-
ging is the diagnostic technique of choice for arrhythmo-
enic RV dysplasia (Fig. 3). Axial and short-axis views of
igure 2. Long-axis view of the heart (black blood images) revealing
rossly hypertrophic left ventricular wall caused by hypertrophic cardiomy-
pathy (arrows).1-weighted spin echo images reveal fatty infiltration, shinned walls, and dysplastic trabecular structures (20).
tandard gradient echo images reveal characteristic regional
all motion changes, localized early diastolic bulging, wall
hinning, and saccular aneurysmal out-pouchings (29,30).
estrictive cardiomyopathy. Primary infiltration of the
yocardium by fibrosis or other tissues leads to restrictive
ardiomyopathy, characterized by normal LV size and
ystolic function, severe diastolic dysfunction, and biatrial
nlargement. The following different restrictive diseases can
e effectively assessed (20).
ARCOIDOSIS. Sarcoid lesions lead to different signal inten-
ities resulting from different stages of the disease. Some
nstances have reported high intensity areas in T2-weighted
mages, whereas other instances have reported a central low
ntensity area on T1- and T2-weighted imaging surrounded
y a high signal ring (31). Gadolinium has also been
eported to accumulate in the sarcoid lesions and is thought
o be due to fibrotic non-active granulomatous nodules with
nflammatory response of the surrounding tissue (32). Thus,
2-weighted followed by T1-weighted spin echo tech-
iques in short and long axis with and without gadolinium
ould be useful to detect and/or exclude sarcoid granulomas.
EMOCHROMATOSIS. Magnetic resonance imaging reveals
xtensive signal loss in native T1- and T2-weighted images
33) as a result of the very strong paramagnetic properties of
ron. The pattern of focal signal loss in a dysfunctional
yocardium associated with an abnormally “dark” liver
ight be sufficient to confirm the diagnosis of systemic
emochromatosis.
MYLOIDOSIS. Magnetic resonance imaging can be useful in
he detection of amyloidosis and its differentiation from HCM.
thickness of the atrial septum or the right atrial posterior wall
6 mm is fairly specific for amyloid infiltration (34). Tissue
haracterization in cardiac amyloidosis has not been well
igure 3. Black blood images of the heart showing bright signals in the
ight ventricular (RV) free wall (arrow) consistent with fatty deposits
uggestive of arrhythmogenic RV dysplasia. LV  left ventricle.tudied, and few data are available. In one study, there was a
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ium in comparison to the reference tissue (34).
NDOMYOCARDIAL FIBROSIS. Endomyocardial fibrosis
also termed Loeffler’s endocarditis) is characterized by
xtensive subendocardial fibrosis, apical thrombus forma-
ion, and progressive diastolic dysfunction (20). The mor-
hologic and functional features can be well quantified by
RI. The fibrosis may be visible as a dark apical rim in
right blood prepared gradient echo sequences (35).
SSESSMENT OF PERICARDIAL DISEASE
he T1-weighted spin echo imaging demonstrates normal
ericardium as a thin band (2 mm) of low signal, bordered
y epicardial and pericardial fat, which has a high signal. A
hickness of 4 mm is considered abnormal and suggestive
f fibrous pericarditis (36) (Fig. 4). The use of contrast-
nhanced MRI may help better delineate the pericardium in
ases of effusive-constrictive pericarditis (37). Breath-hold
r real-time cine gradient echo images of the ventricles and
hase velocity mapping of the cardiac valves may be helpful
n assessing the significance of pericardial pathology.
VALUATION OF CARDIAC
ND PARACARDIAC MASSES
xial black blood bright blood cine MRI is excellent for
elineating the morphologic details of a mass (including
xtent, origin, hemorrhage, vascularity, calcification, and
ffects on adjacent structures). Benign myxomas (the most
ommon cardiac tumor) appear brighter on T2 weighting
han myocardium, and cine images may reveal the charac-
eristic mobility of the pedunculated tumor. Lipomas appear
righter on spin echo T1-weighted images, and the diag-
osis is verified by a decrease in signal intensity using a fat
re-saturation technique. An acute thrombus appears
righter than myocardium on T1-weighted images because
igure 4. Black blood images of the heart in long axis revealing thickened
ericardium (arrows). DA  descending aorta; LV  left ventricle; RV 
ight ventricle.f an alteration in paramagnetic properties (38). aVALUATION OF CONGENITAL HEART DISEASE
agnetic resonance imaging plays an important role in
iagnosing and serially following patients with various
ongenital heart diseases, complementary to echocardiogra-
hy. It identifies atrial and ventricular septal defects, and
hase velocity mapping at the level of the shunt allows
alculation of shunt fraction (Qp/Qs ratio) (39). Using
ifferent imaging sequences including MR angiography,
esions such as anomalous pulmonary venous return, trans-
osition of great vessels, aortic rings, truncus arteriosus,
ouble outlet RV, tetralogy of Fallot, pulmonary atresia, and
ulmonary artery stenosis can be diagnosed (40). Magnetic
esonance imaging can also be used to follow up patients for
ffects and complications after corrective surgery (40). Mag-
etic resonance angiography can also be useful to diagnose
enous anomalies such as persistent superior vena cava or
nterruption of the inferior vena cava with azygous contin-
ation (40).
VALUATION OF VALVULAR DISEASES
chocardiography with color Doppler is usually the first-
ine imaging modality for diagnosing valvular diseases.
agnetic resonance imaging is generally reserved for use
hen other modalities fail or provide suboptimal informa-
ion (38). Semiquantitative assessment of valvular stenosis
r regurgitation can be obtained by measuring the area of
ignal void on gradient echo images. The duration or extent
f the signal void correlates with the severity of aortic
tenosis, and the total area of signal loss correlates with the
everity of mitral regurgitation (41). Magnetic resonance
maging has a very high sensitivity (98%), specificity (95%),
nd accuracy (97%) for diagnosing aortic and mitral regur-
itation (40). Phase contrast MR allows assessment of the
everity of valvular stenosis (measures peak jet velocity) by
alculating the valve orifice area and the transvalvular
ressure gradient (38).
VALUATION OF AORTIC DISEASES
hree-dimensional MR angiography, using a T1-
eighted pulse sequence after a bolus intravenous injec-
ion of gadolinium chelate, is an accurate non-invasive
maging modality for assessment of the aorta (42) (Fig.
). Contrast-enhanced MRI has higher sensitivity and
pecificity (98% and 98%, respectively) compared with
omputed tomography (94% and 87%, respectively) and
ransesophageal echocardiography (98% and 77%, respec-
ively) in the diagnosis of aortic dissection (40). It is
seful to evaluate the extent and localization of the
ntimal flap, associated aortic insufficiency, evidence of
ntrapericardial hemorrhage, relationship with branched
essels, and separation of true and false lumen (40). In
ases where aortic dissection occurs without an intimal
ap (intramural hematoma or as a result of aortitis), an
dditional delayed T1-weighted image after contrast
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Cardiovascular Magnetic Resonance Imaging September 15, 2004:1164–71dministration is recommended. This reveals concentric
hickening of the aortic wall with increased intramural
ignal intensity (intramural hematoma) and enhancement
f the aortic wall and surrounding structures (aortitis)
41).
Magnetic resonance imaging can also be very useful in the
ssessment of thoracic aneurysms by demonstrating its
ength, site, morphology, relationship to branch vessels, and
resence of a thrombus or penetrating ulcer. It can aid in the
nitial assessment and longitudinal follow-up (both pre- and
ostoperatively) of congenital aortic disorders such as
arfan syndrome and coarctation of the aorta.
VALUATION OF THE PULMONARY VEINS
ontrast-enhanced MRI has a clinical role in evaluating
ulmonary veins, to determine anomalous pulmonary ve-
ous return, and particularly as an adjunct to the radiofre-
uency ablation of the pulmonary vein pathways causing
trial fibrillation. Magnetic resonance imaging is useful to
dentify and size the pulmonary veins at baseline, and serial
maging and assessment of the size of these veins is very
seful in detecting pulmonary vein stenosis, a frequent
omplication of the ablation procedure (43).
VALUATION OF MYOCARDIAL
ERFUSION AND ISCHEMIA
agnetic resonance imaging is emerging as a reliable and
seful tool in the assessment of regional LV perfusion (Fig. 6).
fter a rapid intravenous contrast injection, there is a marked
ignal enhancement first in the RV cavity, LV cavity, and then
n the LV myocardium. Gradient echo sequences have been
sed for single-slice (midcavity, short-axis) perfusion MRI in
umans (44,45). Recently, echo planar techniques have been
igure 5. Black blood axial images of the chest showing a dissection
arrow) in the descending aorta (DA). The false lumen has a higher signal
ntensity owing to organized thrombus. AA  ascending aorta; PA 
ulmonary artery; SVC  superior vena cava.mployed for ultrafast multislice MRI (46,47). The peak signalntensity is related to the concentration of the contrast agent in
he local tissue and is directly proportional to the coronary
lood flow. Perfusion MR at rest and after infusion of
harmacologic agents (adenosine and persantine) have been
ompared with standard methods (angiography or radionuclide
cintigraphy) and demonstrated reasonable sensitivity (67% to
3%) and specificity (75% to 100%) (48,49). Additionally,
ombined wall motion assessment further improved the per-
ormance of MRI to detect ischemia.
Dobutamine stress MR has also been studied as a stress
esting modality. Stress induced wall motion abnormality is
n early and reliable sign of myocardial ischemia. Quanti-
ative assessment of systolic wall thickening provides better
esults than does the visual assessment of response to
obutamine (sensitivity of up to 91%, specificity of approx-
mately 80%) (50,51). For high-dose dobutamine stress
ests, fast techniques (echo planar imaging, turbo-gradient
cho sequences, or real-time imaging) should be used in
reference to conventional MR sequences as this signifi-
antly reduces scan time, improves image quality, and
nables rapid detection of wall motion abnormalities (52).
ecause high-dose dobutamine stress MR is highly accurate
nd can be performed in less than 30 min, it has the
otential to replace dobutamine stress echocardiography in
atients with non-diagnostic or suboptimal echocardio-
raphic image quality (52).
During stress examination using vasodilators or dobutamine,
onitoring of the patient is mandatory. Continuous monitor-
ng of heart rate, rhythm, blood pressure, pulse oximetry, and
ymptoms is necessary. Assessment for wall motion abnormal-
ties is done after every dose increment of dobutamine and at
eak stress after administration of adenosine/persantine (52).
urrently, stress MRI precludes analysis of ST-segment,
eal-time display of wall motion, and it requires repeated
reath holds (15 to 16 s) throughout the study (50). This
ay impede communication with the patient and, if symptoms
igure 6. First-pass short-axis image of the heart obtained after injection
f contrast agent revealing a hypoenhanced area in the lateral wall (arrow)
onsistent with myocardial ischemia. LV  left ventricle; RV  right
entricle.
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long with the contraindications that are identical to those for
tress echocardiography or myocardial perfusion scintigraphy,
pecific contraindications for MR, such as pacemakers, defi-
rillators, and cerebral clips need to be taken into consider-
tion.
ORONARY ARTERY IMAGING
maging of the coronary arteries using MR is a challenging
roposition (because of the small caliber of the coronaries,
ortuosity, constant cardiac/respiratory motion, and being
urrounded by epicardial fat that appears bright on MRI);
ence, this modality is predominantly used in research
enters. In a multicenter trial evaluating coronary MR
ngiography, MR had a sensitivity of 100%, specificity of
5%, and accuracy of 87% for the diagnosis of coronary
rtery disease in patients with left main or three-vessel
isease (54). With the development of more sophisticated
equences and better contrast agents, routine non-invasive
R coronary angiography might soon become a reality.
However, the role of MRI in assessing for the anomalous
rigin and course of coronary artery is well established.
ndeed, MR techniques have shown excellent results in the
efinition and identification (93% to 100% of cases) of
nomalous coronary arteries. Also, MRI can aid in classi-
ying cases that were not classified or were misclassified by
onventional angiography (55,56).
Unlike native coronary arteries, MR has a definite current
ole in the assessment of saphenous vein and internal
ammary bypass grafts with a sensitivity, specificity, and
ccuracy in the 90% range. It is also useful in detecting
aphenous vein graft aneurysms that require surgical repair.
owever, metallic clips, graft markers, and sternal wires
ay cause local artifacts (57).
RI OF THE ATHEROSCLEROTIC PLAQUE
agnetic resonance imaging has been used to assess the
egression and tissue characterization of atherosclerotic
laques in different vascular territories, including aorta,
arotid arteries, and now, coronary arteries. Atherosclerotic
laque in the aorta can be assessed volumetrically and
haracterized using double inversion-recovery fast echo
equences to suppress the signal from flowing blood (58,59).
tudies have also been performed using transesophageal
RI to improve the signal intensity (58). Similarly, carotid
rteries have been imaged, and attempts at plaque charac-
erization have been performed (60). More recently, coro-
ary vessel wall imaging has been attempted using black
lood MRI (61). This will serve as an important tool to
ssess regression of the coronary plaque in the future,
articularly with the advent of sophisticated pulse sequences
nd 3-T MR systems.EWER APPLICATIONS AND MOLECULAR IMAGING
s MR technology evolves, newer therapeutic applications
re being developed. Preliminary work is already underway
n developing newer intravascular MR contrast agents,
ontrast agents specific to image atherosclerotic plaque
omponents, specific MR-compatible catheters for electro-
hysiology studies/ablation as well as interventional cardi-
logy related procedures, which might alter the way we will
ractice cardiology in the future. It is anticipated that such
evelopments will be coupled to the utilization of molecular
arkers to index biologic processes to, and allow for, their
n vivo visualization. This combination of biochemical
arkers and imaging methodology ushers an era of molec-
lar imaging during which much progress in the diagnosis
nd treatment of cardiovascular disease is anticipated.
ONCLUSIONS
agnetic resonance imaging is the newest, most complex
nd rapidly emerging non-invasive test of choice for patients
ith a multitude of cardiovascular problems. Its emerging
ole as one of the dominant imaging modalities in most
acets of clinical cardiology cannot be understated. It has
ntered an important phase in its evolution, with an
nticipated exponential growth in its current applications
nd through the development of newer molecular imaging
pplications.
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lalock 524, Johns Hopkins Hospital, 600 North Wolfe Street,
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